Showing results (61-70 of 314) with videos related to
Sort By:
Pageof 32
Neuro-Oncology|April 18, 2001
Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecinA J Janss, A Maity, C B Tang, et al.Experimental Cell Research|August 26, 1998
Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell linesA J Janss, C Levow, E J Bernhard, et al.Cancer Research|March 15, 1987
Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1aS Garbisa, R Pozzatti, R J Muschel, et al.The Journal of Biological Chemistry|January 25, 2000
BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expressionT K MacLachlan, K Somasundaram, M Sgagias, et al.International Journal of Radiation Biology|October 8, 2003
Farnesyltransferase inhibitors as radiation sensitizersT B Brunner, A K Gupta, Y Shi, et al.Cancer Research|May 1, 1998
Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenesE J Bernhard, W G McKenna, A D Hamilton, et al.Cancer Research|March 31, 2001
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-rasE Cohen-Jonathan, S M Evans, C J Koch, et al.Cancer Research|April 15, 1996
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblastsE J Bernhard, G Kao, A D Cox, et al.The Journal of General Virology|February 1, 1991
Stable expression of rabies virus glycoprotein in Chinese hamster ovary cellsS R Burger, A T Remaley, J M Danley, et al.Cancer Research|January 1, 1990
Synergistic effect of the v-myc oncogene with H-ras on radioresistanceW G McKenna, M C Weiss, B Endlich, et al.Pageof 32